This webinar will be hosted available and live on-demandTuesday, August 9, 20223:00 – 4:30 PM Eastern Time Register NowThanks to advances in techniques for culturing and genetically customizing client cells, researchers established myriad stem cell-based treatments for human illness. Restorative success rates for stem cell-based treatments depend upon whether scientists can provide the proper structural and molecular cues to form the cell types lacking in clients. In addition, to support effective engraftment, researchers should create ways to bypass immune rejection.In this webinar given you by The Scientists Creative Services Team, Kim Vanuytsel and Ryan Flannigan talk about the advanced innovations they integrate to enhance stem cell-based therapies for numerous conditions, consisting of cancer and infertility.Topics to be coveredMulti-omic profiling exposes a molecular signature of human fetal liver hematopoietic stem cell engraftment potentialDeveloping in vitro platforms to bring back sperm production utilizing 3-D bio-printingRegister NowMeet the Speakers: Kim Vanuytsel, PhDResearch Assistant ProfessorDepartment of MedicineCenter for Regenerative MedicineBoston University School of MedicineRyan Flannigan, MDAssistant ProfessorDepartment of Urologic SciencesUniversity of British ColumbiaAdjunct Clinical Assistant ProfessorDepartment of Urology Weill Cornell MedicineSponsored by.